|
COPS5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.494200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.697000E-01 |
| Normal-vs-Stage2 |
6.358000E-01 |
| Normal-vs-Stage3 |
3.859000E-01 |
| Normal-vs-Stage4 |
3.118200E-01 |
| Stage1-vs-Stage2 |
2.923200E-01 |
| Stage1-vs-Stage3 |
8.806600E-01 |
| Stage1-vs-Stage4 |
4.228300E-02 |
| Stage2-vs-Stage3 |
3.186000E-01 |
| Stage2-vs-Stage4 |
8.060400E-01 |
| Stage3-vs-Stage4 |
1.166970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.523000E-01 |
| Normal-vs-AfricanAmerican |
3.596800E-01 |
| Normal-vs-Asian |
3.893600E-01 |
| Caucasian-vs-AfricanAmerican |
5.718000E-01 |
| Caucasian-vs-Asian |
4.042000E-01 |
| AfricanAmerican-vs-Asian |
5.353400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.001600E-02 |
| Normal-vs-Female |
1.649980E-01 |
| Male-vs-Female |
1.637420E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.054000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.189400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.994200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.523200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.428800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.203800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.926000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.878800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.921600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.852800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.790200E-02 |
| Normal-vs-Grade 2 |
5.388400E-01 |
| Normal-vs-Grade 3 |
1.817430E-01 |
| Normal-vs-Grade 4 |
1.268200E-01 |
| Grade 1-vs-Grade 2 |
1.055850E-01 |
| Grade 1-vs-Grade 3 |
6.379900E-03 |
| Grade 1-vs-Grade 4 |
4.756800E-03 |
| Grade 2-vs-Grade 3 |
5.421600E-02 |
| Grade 2-vs-Grade 4 |
6.040300E-02 |
| Grade 3-vs-Grade 4 |
5.902000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.646800E-01 |
| Normal-vs-ccB subtype |
4.597500E-02 |
| ccA subtype-vs-ccB subtype |
2.716500E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.324400E-01 |
| Normal-vs-N1 |
7.077400E-01 |
| N0-vs-N1 |
6.101800E-01 |
|
|
